REAL-TIME ASSESSMENT OF HOMOLOGOUS RECOMBINATION DEFICIENCY DURING OVARIAN CANCER TREATMENT

$697,455FY2017Department of the ArmyDOD

University Of Washington, Seattle WA

Investigators